Characterizations of alphaalpha-well-posedness for parametric quasivariational inequalities defined by bifunctions

The purpose of this paper is to investigate the well-posedness issue of parametric quasivariational inequalities defined by bifunctions. We generalize the concept of $alpha$-well-posedness to parametric quasivariational inequalities having a unique solution and derive some characterizations of $alpha$-well-posedness. The corresponding concepts of $alpha$-well-posedness in the generalized sense are also introduced and investigated for the problems having more than one solution. Finally, we give some sufficient conditions for $alpha$-well-posedness of parametric quasivariational inequalities

The influence of nitrogen doping of the acceptor in orange–red thermally activated delayed fluorescence emitters and OLEDs

Funding: C. Si thanks the China Scholarship Council (201806890001). D.S acknowledges support from the Royal Academy of Engineering Enterprise Fellowship (EF2122-13106). The St Andrews team thanks EPSRC for financial support (EP/P010482/1). X.-H. Zhang acknowledges support from the National Natural Science Foundation of China (Grant Nos. 52130304, 51821002), Suzhou Key Laboratory of Functional Nano & Soft Materials, Collaborative Innovation Center of Suzhou Nano Science & Technology, the 111 Project.Nitrogen-containing polycyclic aromatic hydrocarbons (N-PAH) have been widely used as deep lowest unoccupied molecular orbital (LUMO) acceptors in donor-acceptor (D-A) red thermally activated delayed fluorescent (TADF) emitters and their use in organic light-emitting diodes. However, most of the studies have focused disparately on donor/acceptor combinations to yield efficient emitters, while it is rare that there is a methodological study to investigate the influence of the nitrogen (N) doping ratios on the ground and excited states of PAH acceptors. Here, we report a family of four different N-PAH acceptors containing different numbers of nitrogen atoms within the N-PAH and their use in D-A TADF emitters, DMACBP, DMACPyBP, DMACBPN and DMACPyBPN, when coupled to the same donor, 9,9-dimethyl-9,10-dihydroacridine (DMAC). As the nitrogen content in the acceptor increases the LUMO becomes progressively more stabilized while the singlet-triplet energy gap (ΔEST) decreases and the rate constant for reverse intersystem crossing (kRISC) increases. In particular, introducing nitrogen at the 10-position of the dibenzo[a,c]phenazine (BP) leads to a more than ten-fold enhancement in kRISC in DMACPyBP and DMACPyBPN compared to DMACBP and DMACBPN. Among the OLEDs with all four emitters that with DMACBPN demonstrates the highest EQEmax of 19.4% at an emission peak of 588 nm. while the deepest red emitting device employed DMACPyBPN (λEL = 640 nm) with an EQEmax of 5.4%.Publisher PDFPeer reviewe

糖尿病培训手册在培养糖尿病护士的应用

Objective: To explore the nursing service mode for specialized nurses in diabetes and its application effect. Methods:In view of the actual situation of our hospital, a special training manual named with Diabetes training manual was prior composed. 40 specialized nurses in diabetes were trained with the special training manual. Training lasted for 3 months. After the training, the specialized nurses were assessed with the specialty knowledge of Diabetes Mellitus, the skill of clinical procedures, and the knowledge about patients' health education. Results: The skill of the trained nurses was improved. The satisfaction of patients was enhanced.Conclusion: Diabetes training manual can be used for specialized nurses in diabetes.目的  探讨糖尿病护士培训方式。方法  对2013年1—10月本院内分泌科的40名糖尿病护士培训,根据以往医院的培训，结合本院实际，应用自编的糖尿病培训手册，最后考核糖尿病专科理论、操作及宣教能力考核，培训时间为3个月。结果  培训前与培训后比较差别有统计学意义（P＜0.05），理论、操作及健康宣教能力较培训前提高；提高了患者及新护士的满意度。结论  糖尿病培训手册可以用于培养糖尿病新护士

Efficient orange organic light-emitting diodes employing a central aniline bridged multiresonant thermally activated delayed fluorescence emitter

Funding: S. W. and J. X. W. thank the China Scholarship Council (201906250199, 202006250026) for support. Dianming Sun acknowledges support from the Royal Academy of Engineering Enterprise Fellowship (EF2122-13106). E. Z.-C. thanks the Engineering and Physical Sciences Research Council (EP/W015137/1, EP/W007517/1). X.-H. Z. acknowledges support by the National Natural Science Foundation of China (Grant No. 52130304, 51821002) and the Collaborative Innovation Center of Suzhou Nano Science & Technology.Multiresonant thermally activated delayed fluorescence (MR-TADF) compounds are attractive for use in organic light-emitting diodes as they show narrowband emission, are bright, and can harvest both singlet and triplet excitons for the emission of light. Reflected in the paucity of examples of orange-to-red emitters, developing MR-TADF emitters that emit beyond the green remains an outstanding materials design challenge. In this work, we report one of the first carbonyl-based orange MR-TADF emitters, DDiKTa-A , which is based on the dimerization of the sky-blue emitting DiKTa through a central aniline bridge. DDiKTa-A emits at λPL of 562 nm and has high photoluminescence quantum yield of 92% in 2 wt% doped films in mCP. DDiKTa-A exhibits temperature dependent steady-state photoluminescence in 2-MeTHF, acting as an indirect indicator of the polarity of the medium. The OLEDs with DDiKTa-A showed an EQEmax of 20.3%, but with significant efficiency roll-off (EQE100 of 13.2%). The EQEmax was improved, and the efficiency roll-off mitigated by incorporating an assistant dopant, 4CzIPN, within the emissive layer of the device. The hyperfluorescence device showed an EQEmax of 24.3%, which decreased to 22.5 and 14.6% at 100 and 1000 cd m−2, respectively.Peer reviewe

Classification of Traditional Chinese Medicine Syndromes in Patients with Chronic Hepatitis B by SELDI-Based ProteinChip Analysis

Traditional Chinese medicine (TCM) syndrome, also called ZHENG, is the basis concept of TCM theory. It plays an important role in TCM practice. There are excess and deficiency syndromes in TCM syndrome. They are the common syndromes in chronic hepatitis B (CHB) patients. Here we aim to explore serum protein profiles and potential biomarkers for classification of TCM syndromes in CHB patients. 24 healthy controls and two cohorts of CHB patients of excess syndrome (n = 25) or deficiency syndrome (n = 19) were involved in this study. Protein profiles were obtained by surface-enhanced laser desorption ionization time-flight mass spectrometry (SELDI-TOF/MS) and multiple analyses were performed. Based on SELDI ProteinChip data, healthy controls and CHB patients or excess and deficiency syndromes in CHB patients were obviously differentiated by orthogonal partial least square (OPLS) analysis. Two significant serum proteins (m/z 4187 and m/z 5032) for classifying excess and deficiency syndromes were found. Moreover, the area under the receiver operating characteristic (ROC) curve was 0.887 for classifying excess and nonexcess syndrome, and 0.700 for classifying deficiency and nondeficiency syndrome, respectively. Therefore, the present study provided the possibility of TCM syndrome classification in CHB patients using a universally acceptable scientific approach

Studies on the inhibitory effect of isavuconazole on flumatinib metabolism in vitro and in vivo

As the validated agent for the treatment of chronic myelogenous leukemia (CML), flumatinib is a novel oral tyrosine kinase inhibitor (TKI) with higher potency and selectivity for BCR-ABL1 kinase compared to imatinib. Many patients experience aspergillosis infection and they may start using isavuconazole, which is an inhibitor of CYP3A4. However, there is no study on their interaction in vitro and in vivo. In the present study, the concentrations of flumatinib and its major metabolite M1 were rapidly determined using an stable ultra-performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) method. The half-maximal inhibitory concentration (IC50) was 6.66 μM in human liver microsomes (HLM), while 0.62 μM in rat liver microsomes (RLM) and 2.90 μM in recombinant human CYP3A4 (rCYP3A4). Furthermore, the mechanisms of inhibition of flumatinib in human liver microsomes, rat liver microsomes and rCYP3A4 by isavuconazole were mixed. Moreover, ketoconazole, posaconazole, and isavuconazole showed more potent inhibitory effects than itraconazole, fluconazole, and voriconazole on HLM-mediated flumatinib metabolism. In pharmacokinetic experiments of rats, it was observed that isavuconazole could greatly change the pharmacokinetic parameters of flumatinib, including AUC(0−t), AUC(0−∞), Cmax and CLz/F, but had no effect on the metabolism of M1. According to the results of in vitro and in vivo studies, the metabolism of flumatinib was inhibited by isavuconazole, suggesting that isavuconazole may raise the plasma concentration of flumatinib. Thus, it is important to take special care of the interactions between flumatinib and isavuconazole in clinical applications

Serum cytokine profiling analysis for zheng differentiation in chronic hepatitis B

Approval document of the research protocol by the Medical Ethics Committee of Shuguang Hospital

Gold-Sensitized Silicon/ZnO Core/Shell Nanowire Array for Solar Water Splitting

Solar water splitting represents one of the most promising strategies in the quest for clean and renewable energy. However, low conversion efficiency, use of sacrificial agents, and external bias for current water splitting system limit its practical application. Here, a gold-sensitized Si/ZnOcore/shell nanowire photoelectrochemical (PEC) cell is reported for efficient solar water oxidation. We demonstrated gold-sensitized n-Si/n-ZnO nanowire arrays exhibited higher energy conversion efficiency than gold-sensitized p-Si/n-ZnO nanowire arrays due to the favorable energy-band alignment characteristics. Without any assistance from an external electrical source and sacrificial reagents, gold-sensitized n-Si/n-ZnO core/shell nanowire array photoanode achieved unbiased water splitting under simulated solar light illumination. This method opens a promising venue to cost-efficient production of solar fuels

Cerebrospinal fluid neurofilament dynamic profiles predict cognitive progression in individuals with de novo Parkinson’s disease

BackgroundNeurofilament light chain protein (NfL) in cerebrospinal fluid (CSF) reflects the severity of neurodegeneration, with its altered concentrations discovered in Parkinson’s disease (PD) and Parkinson’s disease dementia (PD-D).ObjectiveTo determine whether CSF NfL, a promising biomarker of neuronal/axonal damage, can be used to monitor cognitive progression in de novo Parkinson’s disease and predict future cognitive decline.MethodsA total of 259 people were recruited in this study, including 85 healthy controls (HC) and 174 neonatal PD patients from the Parkinson’s Progression Markers Initiative (PPMI). Multiple linear regression and linear mixed effects models were used to examine the associations of baseline/longitudinal CSF NfL with cognitive decline and other CSF biomarkers. Kaplan–Meier analysis and log-rank test were used to compare the cumulative probability risk of cognition progression during the follow-up. Multivariate cox regression was used to detect cognitive progression in de novo PD.ResultsWe found PD patients with mild cognitive impairment (PD-MCI) was higher than with normal cognition (PD-NC) in terms of CSF NfL baseline levels (p = 0.003) and longitudinal increase rate (p = 0.034). Both baseline CSF NfL and its rate of change predicted measurable cognitive decline in de novo PD (MoCA, β = −0.010, p = 0.011; β = −0.0002, p < 0.001, respectively). The predictive effects in de novo PD patients aged >65, male, ill-educated (<13 years) and without carrying Apolipoprotein E ε4 (APOE ε4) seemed to be more obvious and reflected in more domains investigated. We also observed that CSF NfL levels predicted progression in de novo PD patients with different cognitive diagnosis and amyloid status. After an average follow-up of 6.66 ± 2.54 years, higher concentration above the median of baseline CSF NfL was associated with a future high risk of PD with dementia (adjusted HR 2.82, 95% CI: 1.11–7.20, p = 0.030).ConclusionOur results indicated that CSF NfL is a promising prognostic predictor of PD, and its concentration and dynamics can monitor the severity and progression of cognitive decline in de novo PD patients